Growth Metrics

Prothena Corp Public (PRTA) EBITDA Margin (2016 - 2025)

Prothena Corp Public (PRTA) has 14 years of EBITDA Margin data on record, last reported at 115252.38% in Q4 2025.

  • For Q4 2025, EBITDA Margin fell 11219553.0% year-over-year to 115252.38%; the TTM value through Dec 2025 reached 2216.44%, down 210208.0%, while the annual FY2025 figure was 2216.44%, 210208.0% down from the prior year.
  • EBITDA Margin reached 115252.38% in Q4 2025 per PRTA's latest filing, down from 1666.25% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 78.48% in Q3 2021 and bottomed at 163056.0% in Q1 2024.
  • Average EBITDA Margin over 5 years is 17791.63%, with a median of 2710.18% recorded in 2023.
  • Peak YoY movement for EBITDA Margin: tumbled -16045918bps in 2024, then soared 16073701bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 2823.55% in 2021, then surged by 100bps to 0.14% in 2022, then plummeted by -17227855bps to 24846.52% in 2023, then skyrocketed by 88bps to 3056.85% in 2024, then tumbled by -3670bps to 115252.38% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 115252.38% in Q4 2025, 1666.25% in Q3 2025, and 1914.39% in Q2 2025.